Tradestie Institutional Equity Comparison Engine

ASTH vs FOFO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ASTH Overall Edge

ASTH Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Astrana Health Inc. Common Stock (ASTH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ASTH trades at 8.3x Forward P/E with 2.6% operating margin (+7.1% YoY revenue) versus FOFO at N/M Forward P/E and -823.6% operating margin (-72.7% YoY). In options structure, ASTH sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro) against FOFO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ASTH
ASTH 8.3x vs FOFO N/M Fwd P/E
Growth & Margin Winner ASTH
Op Margin 2.6% vs -823.6% ยท YoY +7.1% vs -72.7%
Momentum & Technical Winner ASTH
1Y +31.2% vs -85.9% ยท 52W Pos 32% vs 0%
Options & Structure Winner ASTH
BREAKDOWN (8th %ile IV) vs UNCLASSIFIED (N/A IV)
ASTH NASDAQ
Astrana Health Inc. Common Stock
Services-Management Consulting Services
$28.90
+0.77% 1D
Market Cap $1.4B
1M Return -23.97%
1Y Return +31.18%
Forward P/E 8.3x
Unified AI Score
48.8 / 100 HOLD
Tech 53.0 Fund 55.0 Flow 55.0 Mom 60.0
FOFO NASDAQ
Hang Feng Technology Innovation Co., Ltd. Ordinary Shares
Services-Management Consulting Services
$1.50
-7.41% 1D
Market Cap $12.8M
1M Return -23.86%
1Y Return -85.89%
Forward P/E N/M
Unified AI Score
43.0 / 100 HOLD
Tech 33.0 Fund 54.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ASTH +31.18% FOFO -85.89% Spread: +117.07 pp (ASTH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ASTH TTM Op. Margin: 2.6% FOFO TTM Op. Margin: -823.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ASTH vs FOFO. Trailing 12-month operating profitability (ASTH 2.6% vs FOFO -823.6%) and valuation multiples (ASTH 8.3x vs FOFO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ASTH (10) vs FOFO (0)
Institutional Metric ASTH FOFO Criterion Row Winner
Market Capitalization Scale $1.4B $12.8M Larger Scale ASTH
Trailing P/E Ratio Valuation 26.6x N/M Lower Multiple ASTH
Forward P/E Ratio Valuation 8.3x N/M Lower Multiple ASTH
Revenue Growth (YoY) Growth +7.1% -72.7% Higher Growth ASTH
Operating Margin (TTM) Profitability 2.6% -823.6% Higher Margin ASTH
Net Profit Margin Profitability 1.4% 0.0% Higher Margin ASTH
Return on Equity (ROE) Capital Efficiency 9.8% -169.2% Higher ROE ASTH
52-Week Range Position Momentum 32% ($18โ€“$52) 0% ($2โ€“$15) Stronger Trend ASTH
Beta / 30D Volatility Risk Regime 0.40ฮฒ ยท 60% Vol 0.45ฮฒ ยท 65% Vol Lower Realized Risk ASTH
Unified Institutional Score Composite Signal 48.8 / 100 (HOLD) 43.0 / 100 (HOLD) Higher Composite ASTH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ASTH vs FOFO Buy Guide
ASTH BREAKDOWN
100d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live ASTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FOFO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FOFO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ASTH nor FOFO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.